Related Experiment Video
Updated: May 18, 2026

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021
Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update
1Indiana Insitute for Personalized Medicine and Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN 46202, USA. dflockha@iupui.edu
Abstract:
Monoamine oxidase inhibitors (MAOIs) are effective treatments for depression that has atypical features or that has failed to respond to other antidepressants. However, MAOIs are underused because clinicians are concerned about dietary and drug interactions with this class of medication. Hypertensive crisis and serotonin syndrome can occur in rare cases due to interactions between MAOIs and foods containing tyramine as well as interactions with serotonergic and sympathomimetic agents. A better understanding of the foods and drugs that can cause adverse reactions, as well as knowledge of newer MAOIs with mechanisms of action and delivery methods that reduce these risks, may help clinicians to consider the use of these medications, when appropriate, in their patients with depression.
Related Concept Videos
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Antidepressant Drugs: MAOIs and Other Agents
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Pharmacokinetics: Drug–Drug Interactions
Drug toxicity: Drug–Drug Interaction
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...